Our approach to treating food allergies is to develop a targeted therapy that reduces the potential for a severe anaphylactic reaction from accidental exposure.
We believe by targeting the delivery of the drug to the immune cells in the skin we can offer a meaningful treatment while minimizing the risk of side effects.
We target the drug to the skin’s immune cells using Moonlight’s proprietary platform: TASIS. This involves application of a small, minimally invasive dermal stamp that uses microneedles. The stamp is removed within a few minutes and the administration is complete.
Our first treatment is for peanut allergy.
Designed to reduce risk of anaphylactic reaction
Targeted to immune cells to increase potential for allergen desensitization
Less than 5 minute